American International Group’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-36,760
Closed -$1.21M 320
2024
Q1
$1.21M Buy
36,760
+732
+2% +$22.8K ﹤0.01% 1203
2023
Q4
$981K Buy
36,028
+1,218
+3% +$30.3K ﹤0.01% 1305
2023
Q3
$837K Buy
34,810
+1,917
+6% +$51.4K 0.01% 1327
2023
Q2
$1.05M Buy
32,893
+2,219
+7% +$72K 0.01% 1226
2023
Q1
$939K Buy
30,674
+610
+2% +$24.1K 0.01% 1246
2022
Q4
$1.18M Sell
30,064
-110
-0.4% -$4.93K 0.01% 1139
2022
Q3
$1.44M Buy
30,174
+426
+1% +$24.3K 0.01% 1035
2022
Q2
$1.15M Buy
29,748
+4,334
+17% +$172K 0.01% 1146
2022
Q1
$1.46M Sell
25,414
-1,789
-7% -$117K 0.01% 1140
2021
Q4
$2.17M Sell
27,203
-80
-0.3% -$6.85K 0.01% 1039
2021
Q3
$2.37M Buy
27,283
+958
+4% +$96.2K 0.01% 997
2021
Q2
$3.39M Buy
26,325
+3,071
+13% +$245K 0.01% 935
2021
Q1
$1.86M Buy
23,254
+61
+0.3% +$5.8K 0.01% 1144
2020
Q4
$1.89M Buy
23,193
+2,062
+10% +$101K 0.01% 1102
2020
Q3
$520K Buy
21,131
+13,599
+181% +$337K ﹤0.01% 1574
2020
Q2
$211K Buy
7,532
+261
+4% +$5.63K ﹤0.01% 2083
2020
Q1
$131K Buy
+7,271
New +$158K ﹤0.01% 2150

Other funds holding BEAM

American International Group's BEAM Position: Q2 2024 in Review

American International Group sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 36,760 shares — an estimated $1.21M sold.

American International Group first reported a position in BEAM in Q1 2020 and held it in 17 quarters. The position peaked at $3.39M in Q2 2021. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • American International Group reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 36,760 Beam Therapeutics shares in Q2 2024, an estimated $1.21M.
  • American International Group first reported a position in Beam Therapeutics in Q1 2020 and held it in 17 quarters.
  • American International Group's Beam Therapeutics position peaked at $3.39M in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.